Clinical Trial

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Background: Transcranial magnetic stimulation (TMS) uses magnetic pulses to affect brain activity. A type of TMS called theta burst stimulation (TBS) is approved to treat people with major depression. Researchers have developed a new form of TBS called high-density TBS (hdTBS). They hope hdTBS will work better than TBS. But first they need to test the new treatment in healthy adults. Objective: To test hdTBS in healthy adults. Also, to compare the aftereffects of hdTBS and TBS. Eligibility: Healthy adults aged 22 to 60 years. Design: Participants will have 4 clinic visits over about 3 to 4 weeks. They must abstain from drugs and alcohol and limit caffeine before visits. At their first visit, participants will be oriented to TBS. They will wear a cap and earplugs. A device with round coils will be placed near their head. When a brief electric current passes through the coil, it generates a magnetic pulse that stimulates the brain. Participants may feel a pulling sensation on the skin under the coil. Their fingers may move involuntarily. At their next 3 visits, participants will receive either TBS or sham TBS. A sham TBS uses a low magnetic field to minimize the effects of the treatment. Participants will have up to 9 electrodes placed on 1 arm. These electrodes will measure the electrical activity in their muscles. Each TBS session will be videotaped. At every visit, participants will answer questions about their health, including substance use. They will perform 2 tasks to test their thinking skills. They will perform a test on a computer to test their reaction time....
Protocol Amendment History 318 amendments
This ClinicalTrials.gov record has been amended 318 times since 2025-03-10; most recent amendment 2026-07-24.
Status change: Recruiting → Not Yet Recruiting 2025-12-08
Status change: Not Yet Recruiting → Recruiting 2025-09-03
Trial Details
NCT Number NCT06868914
Lead Sponsor National Institute on Drug Abuse (NIDA)
Conditions Healthy Volunteers
Enrollment 35 participants
Start Date 2026-08-19
Primary Completion 2028-01-13 (estimated)
Study Completion 2028-01-13 (estimated)
Updated on ClinicalTrials.gov 2026-08-14